2149 -- SMA Treatment Acceleration Act of 2009 | Poliscope

SMA Treatment Acceleration Act of 2009

2149

111th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

April 28, 2009

Latest Action

April 29, 2009

Primary Sponsor

Patrick KennedyDemocratic(RI)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

37pct

1d open

vs 6,490 other HR bills in the 111th — cohort avg 44d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Lobbying filings that explicitly cite this bill (31)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (5)

KING & SPALDING LLP (7)WINNING STRATEGIES WASHINGTON (7)PUBLIC STRATEGIES WASHINGTON, INC. (7)WASHINGTON STRATEGIC CONSULTING (3)MUSCULAR DYSTROPHY ASSOCIATION, INC. (7)

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2010 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Cosponsors (119)

Name	Party	State
Adam Putnam	Republican	FL
Albio Sires	Democratic	NJ
Allyson Y. Schwartz	Democratic	PA

Similar Bills (AI)

Bills with similar content found using semantic analysis.

700

118th

Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".

1206

118th

Expressing support for the designation of May 2024 as "Mental Health Awareness Month".

507

119th

Expressing support for the designation of June 10 as "FSGS Awareness Day".

Sources: Congress.gov

Show 27 more cited filings

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2010 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

HR 2149

JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FAMILIES OF SPINAL MUSCULAR ATROPHYclient→WASHINGTON STRATEGIC CONSULTING

2010 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Seek support for and passage of the SMA treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158)

Client expense: Not reported · Firm income: $10,000

H.R. 2149

mr SPENCER PERLMAN ms LAUREN WATTS

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2010 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy and H.R. 3790, Competitive Bidding Repeal

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR WILLIAM TALMADGE

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2010 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790

Client expense: $150,000 · Firm income: Not reported

H.R. 2149

ANNIE KENNEDY DAVID MILLER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FAMILIES OF SPINAL MUSCULAR ATROPHYclient→WASHINGTON STRATEGIC CONSULTING

2010 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Seek support for and passage of the SMA Treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158).

Client expense: Not reported · Firm income: $10,000

H.R. 2149

mr SPENCER PERLMAN ms LAUREN WATTS

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2010 · third_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2010 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

HR 2149

JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2010 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790

Client expense: $60,000 · Firm income: Not reported

H.R. 2149

ANNIE KENNEDY DAVID MILLER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2010 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR WILLIAM TALMADGE

Government targets: HOUSE OF REPRESENTATIVES, SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2010 · second_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2010 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

HR 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

HR 2149

ALICIA D'ALESSANDRO JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2010 · first_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups

Client expense: $70,000 · Firm income: Not reported

HR 2149

DAVID MILLER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2010 · first_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy and H1N1 distribution plans for high priority groups

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR WILLIAM TALMADGE

Government targets: HOUSE OF REPRESENTATIVES, SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2010 · first_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY ROBERT ZUCKER

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2010 · first_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 2149 / S.1158 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

H.R. 2149

ALICIA D'ALESSANDRO JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2009 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups

Client expense: $70,000 · Firm income: Not reported

HR 2149

DAVID MILLER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2009 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy, H.R. 3790, Competitive Bidding Repeal Act, and H1N1 distribution plans for high priority groups

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR GEORGE CRAWFORD WILLIAM CLARKSON WILLIAM TALMADGE

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2009 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $10,000

H.R. 2149

ALICIA D'ALESSANDRO JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2009 · fourth_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY ROBERT ZUCKER

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2009 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.

Client expense: $70,000 · Firm income: Not reported

H.R. 2149

ANNIE KENNEDY DAVID MILLER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2009 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy, and H1N1 distribution plans for high priority groups.

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR WILLIAM CLARKSON WILLIAM TALMADGE

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2009 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

H.R. 2149

ALICIA D'ALESSANDRO JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2009 · third_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY ROBERT ZUCKER

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

FIGHTSMAclient→PUBLIC STRATEGIES WASHINGTON, INC.

2009 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 2149 / S.1158 2009 Spinal Muscular Atrophy Treatment Acceleration Act

Client expense: Not reported · Firm income: $20,000

H.R. 2149

ALICIA D'ALESSANDRO JOSEPH O'NEILL STEVEN EICHENAUER

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→MUSCULAR DYSTROPHY ASSOCIATION, INC.

2009 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, and legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158)

Client expense: $60,000 · Firm income: Not reported

H.R. 2149

ANNIE KENNEDY

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MUSCULAR DYSTROPHY ASSOCIATION, INC.client→KING & SPALDING LLP

2009 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and H.R. 2149/S. 1158, legislation to accelerate research and treatment of spinal muscular atrophy

Client expense: Not reported · Firm income: $30,000

H.R. 2149

ALLISON KASSIR

Government targets: SENATE

SPINAL MUSCULAR ATROPHY (SMA) FOUNDATIONclient→WINNING STRATEGIES WASHINGTON

2009 · second_quarter · Medical/Disease Research/Clinical Labs

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act

Client expense: Not reported · Firm income: $30,000

H.R. 2149

DONNA MULLINS LAURA LAY

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE